Cancer Screen analyses germline mutations across 49 genes that are associated with 17 types of hereditary cancer, including some of the most commonly occurring cancers such as hereditary breast, ovarian, colorectal, prostate and stomach cancer.

Who is it for?

• Patients who have a family history of cancer and are worried about their own genetic risk;
• Individuals from a family with a present known mutation;
• Women who had breast cancer diagnosed by the age of 50 or have had multiple breast or ovarian cancers and men who have had breast cancer;
• Anyone who wants to know more about his/her genetic predisposition.

Clinical benefits

Improving outcomes
Potentially improves outcomes for patients identified as carriers of mutations with targeted surveillance or early intervention.
Avoiding unnecessary interventions
Avoids unnecessary interventions for patients who do not test positive for the mutation known in their family.
Counselling patients
Counsel patients on the underlying genetic causes of hereditary cancer in their family.